Innovative Paths to a Trusted PartnerBG Medicine

Investor Relations

BG Medicine is a privately held company founded in 2000 by Flagship Ventures. Since its inception it has received over $90 Million in equity funding from its institutional investors Flagship Ventures, Gilde Investment Management, Legg Mason Capital Management, GE Asset Management, and SMALLCAP World Fund—and from strategic investors, including Humana, Royal Philips, and Waters Corporation.


For investment inquiries contact: Stacie Rader, Senior Vice President, Executive Operations
EM: srader@bg-medicine.com , PH: 781-890-1199